At CHF Solutions, we pride ourselves on our culture. We have developed a culture founded in the ethical values that brings our leaders, staff and investors, together to work towards becoming a leader in the treatment of heart failure and related conditions.
Official Corporate Documentation
Indication: The Aquadex FlexFlow® System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy; and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.